Critics believe Donald Trump's nominee to lead Health and Human Services poses a threat to the achievements of a ...
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
director of the FDA's Center for Drug Evaluation and Research, said in a news release. The agency's proposed order would remove oral phenylephrine from the "monograph" of ingredients that ...
Should Kennedy win Senate confirmation, his critics say he is threatening the achievements of a science-based public health ...
Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and ...
The U.S. Food and Drug Administration's ("FDA") new advisory committee on digital health is set to examine its approach for evaluating and ...